Live tape
Top 8, mentions 7d14,365NVDA4,867 mentions▲ +0.04GOOGL2,064 mentions▲ +0.04SPY1,738 mentions▲ +0.06QQQ1,554 mentions▲ +0.05AMD1,212 mentions▲ +0.08SPCX1,112 mentions▲ +0.05TSLA956 mentions▲ +0.04SNDK862 mentions▲ +0.06

Equity · Healthcare

EOLS

NASDAQ

Evolus (EOLS)

7.82 USD −2.25% vs prior close Sep 18, 2026
Evolus, Inc. price graph
27 sessions
9.5 7.5 12 Aug 18 Sep

The line runs 8.14 USD on 12 August through 7.82 USD on 18 September, on a scale from 7.5 to 9.5. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
517.6M USD
Revenue, year to Dec 2025
297.2M USD
EPS, diluted, year to Dec 2025
−0.80 USD
52-week range
4 USD – 9 USD
Avg volume
129.6K

as of Sep 18, 2026

Have Evolus (EOLS) insiders bought or sold shares recently?

In the 90 days to 10 Nov 2026, Evolus insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 22 Dec 2025, show no open-market purchase.

Form 4, 90 days to 10 Nov 2026, newest reported trade 2 Sep 2026

0buys
1sells
$950Knet sold
0other filings
Have Evolus (EOLS) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
02 Sep 2026MOATAZEDI DAVIDSee RemarksSell105,108950K USD

Which funds hold Evolus (EOLS)?

7 of the 45 institutional funds we track reported a Evolus position for the quarter ended 30 Jun 2026 — a combined 31.7M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Evolus (EOLS)?
FundPositionSharesValueShares q/q
Millennium ManagementHeld (±25%)1,787,92912.4M USD+22.4%
Point72 Asset ManagementNew position1,508,51810.5M USD
Citadel AdvisorsTrimmed506,3543.5M USD−27.3%
D. E. Shaw & Co.Trimmed336,9012.3M USD−39.7%
Renaissance TechnologiesHeld (±25%)302,5692.1M USD−10.8%
AQR Capital ManagementAdded97,563677K USD+280.0%
Tudor Investment CorpNew position31,547219K USD
Man GroupExited
Marshall WaceExited

What has been filed or recorded for Evolus (EOLS)?

The filings we hold for Evolus, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Evolus (EOLS)?
And
13 Oct 2026Fails to deliverShares failed to deliver223 shares2K USD notional · <0.001% of shares out
09 Oct 2026Fails to deliverShares failed to deliver1,222 shares10K USD notional · 0.002% of shares out
05 Oct 2026Fails to deliverShares failed to deliver1,295 shares9K USD notional · 0.002% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.19 USDRevenue $78M
30 Sep 2026FinancialsTotal assets283.8M USDat period end
30 Sep 2026FinancialsTotal equity−37.8M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.12 USDRevenue $84M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.16 USDRevenue $73M
31 Dec 2025Annual reportFY 2025 reportedEPS −0.80 USDRevenue $297M
31 Dec 2025FinancialsRevenue297.2M USDfiscal year
31 Dec 2025FinancialsNet income−51.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.80 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.24 USDRevenue $69M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.27 USDRevenue $69M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.30 USDRevenue $69M
31 Dec 2024Annual reportFY 2024 reportedEPS −0.81 USDRevenue $266M

What do people ask about Evolus (EOLS)?

From live data
What did Evolus shares close at?7.82

Evolus closed at 7.82 USD on 18 Sep 2026, down 2.25% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Evolus’ market cap?517.6M

Evolus is worth 517.6M USD by market value as of 18 Sep 2026, which is the share price times the shares on issue from its SEC filings.

What is Evolus’ revenue?297.2M

Evolus reported revenue of 297.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Evolus insiders bought or sold shares recently?1 sale

In the 90 days to 10 Nov 2026, Evolus insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 22 Dec 2025, show no open-market purchase. See Insiders

Which funds own Evolus?7 of 45

7 of the 45 funds we track reported a Evolus position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Point72 Asset Management and Citadel Advisors. See Funds

When did Evolus last report earnings?−0.19

Evolus last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.19 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings